Markets
BSE See NSE See 48,803.68
259.62 (0.53%)

Sun Pharma share price slips 2 per cent post settlement order by SEBI

Anthony Fernandes / Article rating: 4.3

The shares of the drug manufacturer, Sun Pharmaceutical Industries Ltd had initially touched its 52-week high during the early trade on Friday but soon, slipped by almost 2 per cent after Securities & Exchange Board of India (SEBI) issued an order for settling charges made by a whistleblower.  

Alembic Pharma subsidiary secures USFDA accelerated approval for its partnered asset, Umbralisib

Anthony Fernandes / Article rating: 5.0

Rhizen Pharmaceuticals, a clinical-stage oncology-focussed biopharmaceutical company and subsidiary of Alembic Pharma announced that its novel next-generation PI3K-delta inhibitor, Umbralisib, which was licensed to TG Therapeutics, has secured USFDA accelerated approval.  

1345678910Last

DSIJ MINDSHARE

1345Last

Knowledge

1345Last